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ABSTRACT 
 
Fumonisin B1 (FB1) is a widespread contaminant of crops and is produced as a secondary 
metabolite of fungi. It has been found to disrupt sphingolipid metabolism, cause epigenetic 
modifications and induce cellular toxicity that can manifest through oxidative stress and 
apoptosis. Although implicated in animal toxicity including kidney cancer in rats, FB1 effects 
in the human kidney have not been explored. Allicin is a biological component of garlic that 
has been widely studied for its health benefits including its anti-cancer and antioxidant 
properties. This study evaluated allicin as a possible therapeutic measure for FB1-induced 
cytotoxicity in Hek293 cells. Both FB1 and allicin decreased cellular viability (MTT assay) 
in a dose-dependent manner and generated IC50 values of 215 µM and 3.905 µM respectively. 
Three 24 h treatments (FB1, allicin and combined FB1+allicin) were compared to untreated 
cells for induction of apoptosis and oxidative stress. Luminometry was used to determine 
cytotoxicity (lactate dehydrogenase assay), caspase activity and mitochondrial toxicity 
(apoptosis), and quantify intracellular ROS (iROS) and glutathione (GSH) (oxidative stress). 
Free radical production was estimated by the TBARS and NOS assays respectively, while 
DNA damage was evaluated using the comet assay. Western blotting confirmed the 
expression of various antioxidant and apoptotic proteins, and superoxide dismutase 2 (SOD2) 
transcripts were quantified using qPCR. ATP concentration was increased for all treatments, 
but mitochondrial toxicity was increased in the allicin treatment. While lipid peroxidation 
decreased, luminometry results indicate that iROS was increased and was accompanied by a 
corresponding decrease in SOD2 and catalase protein expression. Depletion of GSH was 
consistent with increased GPx1, HSP70 and Nrf2 protein expression suggesting the presence 
xiv 
 
of oxidative stress. SOD2 transcripts were only increased in the allicin treatment. Apoptosis 
was initiated as indicated by increased caspases 8 and 9, and pro-apoptotic Bax protein 
expression, but caspase 3/7 was not activated for the FB1 treatment. However, DNA 
fragmentation and cPARP were increased for all treatments suggesting that apoptosis was 
executed. Overall, FB1 and allicin individually and combined induced oxidative stress by 
increasing ROS and decreasing antioxidants. Apoptosis was also induced, although in a 
caspase independent manner in the FB1 treatment. Overall, allicin did not ameliorate the 
effects of FB1 in Hek293 cells. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Background 
Plants form a vital part in the provision of energy to sustain normal metabolic function. However, the 
plant based foods consumed may contain harmful substances that arise due to contamination of the 
plant. Notable examples are toxic fungal metabolites such as fumonisin that are not removed by 
washing, heating or food preparation methods; exposure results in diverse toxicity ranging from 
immunotoxicity to cancer. Conversely, the organosulphur-containing herbal constituents that are 
added to enhance the flavour of food during cooking may confer health-benefits when consumed. 
Onion and garlic are among the plants that contain these useful substances. Garlic is renowned for its 
potential anti-cancer properties.  
 
Fumonisin B (FB) mycotoxins are produced as secondary metabolites by fungi including Fusarium 
verticillioides (formerly called Fusarium moniliforme), Fusarium proliferatum and Aspergillus niger. 
They are known to contaminate crops such as maize, wheat and other grain products. Fumonisin B1 
(FB1) is the most toxic member of the 28 types of the fumonisin family that have been characterised 
(Miller et al., 1993, Berek et al., 2001, Schmale and Munkvold, 2009, De Baere et al., 2018).  
 
Human and animal exposure to FB1 occurs via consumption of contaminated maize and other maize 
products. Exposure to FB1 produces varying clinical symptoms from species to species and includes 
pulmonary oedema in pigs, leukoencephalomalacia in horses and oesophageal cancer (OC) in humans 
(Harrison et al., 1990, Kellerman et al., 1990, Van der Westhuizen et al., 2010). In vivo studies 
suggest the existence of fumonisin-induced carcinogenicity, immunosuppression, hepatotoxicity and 
nephrotoxicity in laboratory animals (Howard et al., 2001, De Baere et al., 2018). 
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When tested, FB1 is neither genotoxic nor mutagenic according to standard protocols for genotoxic 
carcinogens, meaning it has no direct mechanism by which it affects DNA  (Fink‐Grernmels, 1999). 
The accepted mechanism for FB1 cytotoxic effects is dysregulation of sphingolipid metabolism, 
however a study by Chuturgoon et al. (2014) has proposed an alternative mechanism of cytotoxicity 
which involves histone demethylation and DNA hypomethylation (Chuturgoon et al., 2014). 
Furthermore, FB1 exposure has been shown to induce oxidative stress and thus play a role in 
carcinogenicity and toxicity. FB1 was also found to activate apoptosis in many cell lines, primary cell 
cultures as well as in vivo (Domijan, 2012). An epigenetic mechanism of CpG promoter DNA 
methylation may play a big part in FB1 toxicity as suggested by a study done on rat kidney and liver 
cells (Klarić et al., 2007, Sancak and Ozden, 2015, Demirel et al., 2015). 
 
FB1 is poorly absorbed and rapidly eliminated, a characteristic that could be attributed to the polar 
nature of this mycotoxin. Excretion occurs in both faeces and urine. In fact, urinary FB1 may be used 
to assess human exposure to FB1 and suggests ongoing exposure of the urinary system, including the 
kidney to FB1. A study by Howard et al. (2001) using rats and mice found that FB1 was a renal 
carcinogen in male rats’ diet at higher dosages (Howard et al., 2001), this finding supported a study 
that hypothesised that FB1 can be carcinogenic at increased levels of exposure (Dragan et al., 2001). 
The inhibition of sphingolipid synthesis was accompanied by decreased cell proliferation in pig 
kidney epithelial cells (LLC-PK1, renal proximal tubule epithelial cells developed from pigs) 
following exposure to fumonisins (Abado-Becognee et al., 1998). FB1 was also found to target the 
proximal tubular epithelium cells in kidneys of rabbits and presented with toxin-induced renal failure 
(Gumprecht et al., 1995). It is therefore necessary to assess the effect of FB1 in human kidney cells. 
 
Garlic (Allium sativum) is a well-known food additive with many postulated health benefits that are 
attributed to the compound allicin (diallyl thiosulfinate) (Amagase, 2006). However, allicin is not 
present in garlic cloves; rather this unstable organosulphur compound is liberated when whole garlic 
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is macerated. Chopping, crushing or chewing garlic results in the release of alliinase, the enzyme 
responsible for the conversion of alliin to allicin. Allicin is found to have numerous biological effects 
such as anti-cancer, anti-microbial, anti-viral and anti-bacterial activities. Studies have shown that 
the anti-cancer properties may be due to inhibition of cancer cell proliferation or induction of 
apoptosis. In addition, allicin possesses powerful antioxidant properties (Hirsch et al., 2000, Oommen 
et al., 2004).  
 
1.2 Problem statement 
Consumption of fungal-contaminated maize, wheat and other grain products has adverse effects in 
animals and humans. The mycotoxin FB1 predisposes different species to varying clinical symptoms 
including OC in humans and kidney cancer in rats. The study done by van der Westhuizen et al. 
(2010) on the prevalence of human OC in Southern Africa due to the exposure to FB1 necessitates 
the study on the implication of FB1 in kidney toxicity (Van der Westhuizen et al., 2010). While FB1 
dysregulates apoptosis and induces oxidative stress, allicin induces apoptosis and acts as an 
antioxidant. Therefore, the potential antagonistic effect of allicin as an inexpensive and 
implementable preventative measure against FB1-induced cytotoxicity warrants investigation. 
 
1.3 Hypothesis 
FB1 induced cytotoxicity in human kidney cells may be reduced by co-exposure to allicin. 
 
1.4  Aim 
This study aimed to determine the cytotoxic effects of FB1 in human kidney cells and the ability of 
allicin to ameliorate these effects.    
 
1.5 Objectives 
The objectives are to determine the:  
 IC50 following exposure to a range of FB1 and allicin concentrations respectively 
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 involvement of oxidative stress as a mechanism of FB1-mediated cytotoxicity, and allicin 
response to the cytotoxic manifestations 
 effect of FB1, allicin and a combination of FB1 and allicin exposure on apoptosis induction 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1  Fumonisin B1 
 
2.1.1  Background 
Fumonisins are mycotoxins produced as secondary by-products of Fusarium species (Seefelder et al., 
2003).  Fusarium verticillioides (Sacc.) Nirenberg (previously known as Fusarium moniliforme) and 
Fusarium proliferatum are two of the most prominent Fusarium species that produce fumonisins. 
Due to their geographical distribution and high production levels (Abuja and Albertini, 2001), these 
contaminating species make fumonisin a worldwide contaminant of maize, a dietary staple for human 
food and animal feed (Hendricks, 1999, Hassan et al., 2015).  
  
Twenty eight types of fumonisins have been discovered and characterised into 4 groups namely, 
fumonisin A, B, C and P (FA, FB, FC and FP series) (Abuja and Albertini, 2001). The FB series is 
the most common of all the fumonisins and within it, FB1 is the most notorious in prevalence and 
toxicity. 
  
2.1.2  Structural composition 
FB1 (Figure 2.1) is composed of two units of propane-1, 2, 3-tricarboxylic acid (TCA) that is esterified 
to a 2S-amino-12S,16R-dimethyl-3S,5R,10R,14S,15R-pentahydroxy-eicosane backbone by a diester 
bridge at the C-14 and C-15 hydroxy groups. The presence of the four  free carboxyl  groups, the 
hydroxyl groups and the amino group make FB1 soluble in polar solvents and insoluble in some 
organic solvents (Chu et al., 2012). 
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Figure 2.1 : Structure of FB1 showing  its similarities to sphinganine and sphingosine (Humpf and Voss, 2004). 
 
2.1.3  Mechanism of action 
Fumonisin B1 is similar in structure to the bioactive lipid signaling molecules, sphingolipids (Figure 
2.1). Sphingolipid biosynthesis is a de novo pathway set off by the condensation of serine and 
palmitoyl-CoA catalysed by serine palmitoyl transferase to form 3-keto-dihydrosphingosine. 3-keto-
dihydrosphingosine is then reduced to sphinganine (dihydrosphingosine). The sphinganine is 
subsequently N-acylated by dihydroceramide synthases to generate dihydroceramide which is 
desaturated creating a 4, 5-trans-double bond to form ceramide. This pathway produces and 
culminates in the production of bioactive intermediates comprising sphingosine, dihydroceramide 
and ceramide (Wang et al., 1991, Merrill, 2002).  
 
A study by Wang et al. (1991) found that fumonisins could disrupt the de novo metabolism of 
sphingolipids (Figure 2.2) via the inhibition of ceramide synthase (Wang et al., 1991). The 
consequence of FB1-induced inhibition of ceramide synthase in vivo is the accumulation of 
sphinganine, an occasional increase of sphingosine, high sphinganine/sphingosine ratio, 
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accumulation of 1-phosphate metabolites of sphinganine and sphingosine and low complex 
sphingolipids (Voss and Riley, 2013). These changes represent an important step in fumonisin 
toxicity that sets off a series of reactions which disrupt cell growth, differentiation and cell injury in 
vitro and in vivo.  
 
Figure 2.2 : Schematic representation of sphingolipid biosynthesis in animal cells and the points at which FB1 
inhibits ceramide synthase (Merrill Jr et al., 2001, Stockmann-Juvala and Savolainen, 2008). 
 
An alternative mechanism of action was recently described in a study by Chuturgoon et al. (2014). 
this study associated FB1 with DNA methylation, a major epigenetic modification (Chuturgoon et al., 
2014). 
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2.1.4  Epigenetics 
 Epigenetic modifications are heritable changes in gene activity or function that are not encoded by 
the DNA sequence. Major components of epigenetic modification include DNA methylation, histone 
modification and microRNAs (miRNAs) which contribute to gene expression through altering the 
chromatin structure and DNA accessibility. DNA methylation and histone modification exert their 
actions at the transcriptional level and miRNAs at the post-transcriptional level (Baccarelli and 
Bollati, 2009, Halušková, 2010, Sharma et al., 2010). 
 
2.1.5  Effects of fumonisin B1 in animals 
The effects of FB1 exposure have continuously proven to vary in different species (Stockmann-Juvala 
and Savolainen, 2008, Chuturgoon et al., 2014). Reports have shown FB1 to induce 
leukoencephalomalacia (LEM) in horses (Marasas et al., 1988, Kellerman et al., 1990, Marasas et 
al., 2014), pulmonary oedema in swine (Harrison et al., 1990) and OC in humans (Sydenham et al., 
1990, Rheeder et al., 1992, Yoshizawa et al., 1994, Sun et al., 2007)  FB1 is also renowned for its 
nephrotoxic, hepatotoxic and neurotoxic effects in laboratory animals (Riley et al., 1994, Voss et al., 
1995, Gelderblom et al., 2001, Marasas et al., 2004). 
 
The presence of FB1 in maize and wheat products intended for human consumption has been linked 
to human health risks including OC and neural tube defects (NTD). OC has been epidemiologically 
linked to FB1 contaminated maize in studies done in South Africa  where reports showed that a high 
risk of OC development was proportional to an increased intake of maize (Marasas and WFO, 1988).  
 
Neural tube defects are congenital malformations of the brain and spinal cord that occur when the 
embryonic neural tube fails to close. This common birth defect has been associated with high 
exposure of FB1 in areas known to have high consumption of maize. A hypothesis for this association 
stated that FB1-induced inhibition of ceramide synthase that disrupts sphingolipid biosynthesis and 
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subsequently folate transport causes a decrease in folate uptake that increases the risk of NTD 
(Hendricks, 1999, Marasas et al., 2004, Missmer et al., 2005, Stockmann-Juvala and Savolainen, 
2008). 
 
Many studies have been done on the effects of FB1 toxicity in animals, commonly laboratory animals. 
These effects include hepatotoxicity, nephrotoxicity, immunotoxicity, neurotoxicity and 
pulmonotoxicity. Studies have demonstrated the occurrence of FB1-induced hepatotoxicity and 
nephrotoxicity in laboratory animals through repeated exposure. Gelderblom et al. (1988) found that 
male BD IX rats developed chronic toxic hepatosis when treated with 48 mgFB1/kg body weight daily 
(12 days) then 70 mgFB1/kg body weight daily (9 days) in a 21-day experiment (Gelderblom et al., 
1988). In a study by Voss et al. (1993) both hepatotoxicity and nephrotoxicity were demonstrated in 
a study done on Sprague-Dawley rats (Voss et al., 1993). FB1-induced toxicity in the liver and kidneys 
is a common consequence of various feeding studies (Voss et al., 1993, Riley et al., 1994, Howard et 
al., 2001).  
 
The immunological effects of FB1 have only been studied based on the cytokine profile of different 
cell types and organs. A study on Sprague-Dawley rats demonstrated that FB1 affected the humoral 
immune response of the male rats (Tryphonas et al., 1997). The most common neurotoxic effect of 
FB1, LEM developed through oral or intravenous administration was found in horses (Kellerman et 
al., 1990).  
 
FB1 has been shown to exhibit carcinogenic effects on various cells in animals and humans. The 
International Agency for Research on Cancer (IARC) has classified FB1 as a type 2B carcinogen, a 
possible human carcinogen. A 2-year study by Howard et al. (2001) found FB1 to be a renal 
carcinogen causing renal tubule tumours in male F344 rats at doses 50 and 150 ppm and a 
hepatocarcinogen inducing hepatocellular adenomas and carcinomas in female B6C3F1 mice at doses 
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50 and 80 ppm (Howard et al., 2001). In rat kidney epithelial cells, FB1 was reported to have altered 
global histone modification (Sancak and Ozden, 2015) and in human hepatoma cells, found to have 
induced global DNA methylation (Chuturgoon et al., 2014) which may be linked to the progression 
of cancer, tumourigenesis or cell cycle arrest.   
 
2.1.6  Molecular effects of FB1 exposure 
The two main consequences of FB1 exposure are oxidative stress and apoptosis. Together, these 
processes are responsible for the diverse effects associated with FB1 exposure. 
 
2.1.6.1  Oxidative Stress 
Reactive oxygen species (ROS) are by-products of aerobic respiration in the process of normal 
cellular metabolism (Held, 2012). Oxygen is converted through a series of reduction reactions to 
superoxide (O2
-), hydrogen peroxide (H2O2) and water (H2O) (Figure 2.3). These radical oxygen 
species are counteracted by an arsenal of antioxidant proteins or enzymes. Superoxide dismutases 
(SODs) are known to be the major antioxidant defense proteins, catalysing the conversion of O2
- into 
H2O2 – in the mitochondria, SOD2 (MnSOD) is the isoform responsible for this reaction. The resulting 
H2O2 is further converted to H2O, catalysed by glutathione peroxidase (GPx), catalase or 
peroxiredoxin (Prxs) (Figure 2.3). GPx simultaneously catalyses the formation of oxidised 
glutathione (GSSG) from reduced glutathione (GSH) (Figure 2.3) (Halliwell, 2007, Gupta et al., 
2014). Glutathione is an important antioxidant vastly populated in the liver and is needed by the 
kidneys to maintain homeostasis, making it crucial for the body’s detoxification process (Lash, 2005, 
Zitka et al., 2012). Reduced GSH is a ROS scavenger. On DNA and other biomolecules it demolishes 
oxygen free radicals, radical centers and reactive hydroxyl free radicals (Mytilineou et al., 2002). The 
relative concentration of these antioxidants is controlled by the nuclear factor erythroid 2 (NFE2)-
related factor 2 (Nrf2) (Fukai and Ushio-Fukai, 2011), a transcription factor that exerts cytoprotective 
properties against oxidative stress.   
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Intracellular and/or extracellular ROS are essential for biochemical processes such as cellular 
function, intracellular signaling and defense against microorganisms at low levels (Fukai and Ushio-
Fukai, 2011). However, at increased levels ROS inactivate or deplete antioxidant enzymes (Lushchak, 
2015), resulting in an accumulation or inadequate removal of ROS and  oxidative stress (Fukai and 
Ushio-Fukai, 2011). Oxidative stress therefore is increased toxic levels of ROS production surpassing 
the cell’s ability to counteract the effects. The induction of oxidative stress not only damages tissues, 
but causes genetic instability and disrupts normal cellular functioning (Towner et al., 2003, Mehta et 
al., 2007, Matur et al., 2011, Abbes et al., 2016, Khan et al., 2018b).  
 
Figure 2.3 : Schematic representation of the synthesis and detoxification of ROS (Merksamer et al., 2013).  
 
FB1-induced oxidative stress varies from cell type to host species, demonstrated by studies done on 
OC cells, mice, hens, humans and rats (Towner et al., 2003, Mehta et al., 2007, Matur et al., 2011, 
Abbes et al., 2016, Khan et al., 2018b). In humans, it is postulated that oxidative stress mediates the 
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immunotoxic effects of FB1 (Stockmann-Juvala et al., 2007, Klaric et al., 2008, Domijan et al., 2012). 
The findings of a study by Abbes et al. (2016) further verified the role of FB1 in inducing oxidative 
stress by demonstrating increased levels of oxidative stress markers in mice spleen where ROS 
production was increased overall. It hypothesised that genotoxicity or mutagenicity may be indirect 
consequences of FB1-induced oxidative damage (Hassan et al., 2015, Abbes et al., 2016). It must also 
be noted that cells may respond to oxidative stress by triggering apoptosis. 
 
2.1.6.2 Apoptosis 
 
The regulation of homeostasis and other cellular processes helps maintain cellular functionality. 
Apoptosis is a biological process of programmed cell death marked by cell shrinkage, DNA 
fragmentation and chromatin condensation that occurs as a mechanism of defense that removes 
damaged cells (Kerr et al., 1972, Renehan et al., 2001). This process is controlled by caspases, which 
are initially produced as inactive pre-enzymes (procaspases) before activation through different 
cleavage processes at specific aspartate residues (Shi, 2004, Elmore, 2007). 
 
Apoptosis occurs via the intrinsic and extrinsic pathways (Figure 2.4). The intrinsic pathway is 
triggered by a number of mitochondrial stimuli such as DNA damage, oxidative stress and growth 
factor deprivation. These stimuli produce signals intracellularly mediated by the mitochondria. The 
extrinsic pathway is activated through the binding of death receptors to ligands to transmit apoptotic 
signals (Elmore, 2007, Mukhopadhyay et al., 2014). 
 
The intrinsic pathway, also known as the mitochondrial pathway is mainly regulated by the Bcl-2 
family proteins responsible for mitochondrial membrane permeability (Figure 2.4). They stimulate 
BH3 family proteins that activate BAX and BAK pro-apoptotic effectors. The process is triggered by 
several stimulating factors that disturb the electrochemical gradient, increase membrane permeability 
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and release apoptogenic factors. A disturbance in the mitochondrial membrane integrity results in 
either necrosis and/or the release of cytochrome c into the cytosol which activates initiator caspase 9 
through the assembly of an apoptosome (a multiprotein caspase-activating complex comprised of 
Apaf1 and procaspase 9) that activates effector caspases 3/7 that function to execute apoptosis 
(Hassan et al., 2014, Baig et al., 2017). 
 
The death receptor-mediated pathway is triggered when the signaling mechanism of death domain 
(DD)-containing tumour necrosis factor (TNF) family receptors activates caspases (Figure 2.4). 
Death receptor ligands bind to the plasma membrane forming a death-inducing signaling complex 
(DISC) to activate procaspases 8 and 10. Caspase 8 which contains death effector domains on the N-
terminal prodomains initiates proapoptotic cascade of caspases. Caspase 8 can either activate the 
intrinsic pathway through the activation of tBID which triggers the oligomerisation of Bak to release 
cytochrome c or activates caspase 3 (Figure 2.4). Caspase 3 cleaves inhibitor of caspase activated 
DNase (iCAD) to CAD that leads to DNA fragmentation, apoptotic blebs, apoptotic bodies and 
chromatin condensation (Hassan et al., 2014, Koff et al., 2015). 
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Figure 2.4: Intrinsic and extrinsic pathways of apoptosis (Baig et al., 2017). 
 
Exposure to FB1 results in organ-specific toxic manifestations. Likewise, the induction of apoptosis 
by FB1 is dependent on cell type and species, as well as the concentration (Khan et al., 2018). For 
example, neuroblastoma cells are sensitive to FB1-induced apoptosis (Stockman-Juvala, 2006), while 
apoptosis is inhibited in HepG2 cells (Chuturgoon et al., 2015). A number of animal studies 
investigating the consequences of FB1 exposure describe one of its effects to be apoptosis. This effect 
results from FB1-induced disruption of sphingolipid metabolism by inhibiting the enzyme ceramide 
synthase (Wang et al., 1991, Brenner and Kroemer, 2000, Minervini et al., 2004). Dragan et al. (2001) 
characterised FB1-induced apoptosis as mechanism of action in carcinogenesis (Dragan et al., 2001). 
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2.2 Medicinal plants 
Plants have been used for medicinal purposes for many years. Scientific research as shown their 
health benefits to span from antiseptic properties to the treatment of cancer (Greenwell and Rahman, 
2015). Their wide array of health benefits has since prompted the identification of plant species and 
their extracts for the development of some therapeutic drugs. Among many, Allium sativum  and its 
constituents is one of the most commonly studied plants for its potential to alleviate and prevent 
disease (Amagase, 2006, Iciek et al., 2009). 
 
2.2.1  Allium sativum 
Allium sativum, more commonly known as garlic, is a medicinal plant whose use in different cultures 
has had many beneficial health effects through history. Its biological benefits include anti-cancer 
properties, enhanced immune function, reduced cardiovascular disease risk factors, anti-bacterial, 
anti-fungal and anti-parasitic properties among many (Mikaili et al., 2013, Gruhlke et al., 2016). The 
varying effects of garlic have been attributed to its different preparations under four categories namely 
garlic oil, aged garlic extract (AGE), garlic powder and garlic oil macerate. A common characteristic 
of garlic is its distinct smell caused by oil-soluble sulfur constituents; whole intact garlic comprises 
primary sulfur-containing molecules which include -glutamyl-S-alk(en)yl-L-cysteines and S-alk-
(en)yl-L-cysteine sulfoxides (i.e alliin) (Bhandari, 2012)  
 
2.2.2  Allicin, an organosulphur compound from garlic 
When the plant tissue is damaged or whole garlic is macerated, garlic compounds undergo rapid 
conversion into organosulphur compounds such as allicin (alkyl alkane-thiosulfinate) which 
represents the biologically active component of crushed garlic. Allicin is synthesised via a two-step 
reaction that begins when the enzyme alliinase that hydrolyses alliin within the cytosol to produce 
dehydroalanine and odiferous sulfenic acid (Bat-Chen et al., 2010). A spontaneous condensation 
reaction of two allyl sulfenic molecules (2-propenesulfenic acid) occur forming one allicin molecule 
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(Figure 2.5). Allicin may then be degraded to ajoene by heating, or condense with other allicin 
molecules yielding secondary products including diallyl sulfide (DAS), diallyl disulfide (DADS) and 
diallyl trisulfide (DAT) and dithiins (Figure 2.5). In a different pathway, -glutamyl-cysteines are 
converted to S-allylcysteine (SAC) (Mikaili et al., 2013, Luo et al., 2016).  
 
 
Figure 2.5: The two-step biosynthesis of allicin involves the enzymatic conversion of alliin to 2-
propenosulfenic acid, and subsequent condensation to allicin. Secondary products are formed by various 
meansof. Adapted from (Gruhlke et al., 2016, Luo et al., 2016). 
 
2.2.3  Effects of allicin 
Allicin has been vastly studied for its many health benefits including anti-cancer activity through 
allicin-induced apoptosis and inhibition of cancer cell proliferation in different cell lines (Siegers et 
al., 1999, Hirsch et al., 2000, Bat-Chen et al., 2010). Allicin-induced apoptosis varied in different 
cell lines, and was found to be both caspase-dependent (Oommen et al., 2004, Bat-Chen et al., 2010) 
and caspase-independent (Park et al., 2005) . It has been suggested that inhibition of cell proliferation 
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mediated by allicin may be associated with modulation of tubulin, which interferes with mitotic 
spindle formation and cell division (Prager‐Khoutorsky et al., 2007). 
 
The exact mechanisms by which allicin induces its antioxidant effects remains unclear. However, 
studies have shown it to have free radical scavenging effects, ability to inhibit the production of O2
- 
and react with thiol-containing compounds. This reactive sulfur species also has the ability to oxidise 
GSH and cysteine residues in various proteins because of its membrane permeability. Studies have 
also shown that in the presence of ROS, allicin induces phase II detoxification and upregulates nuclear 
factor erythroid-related factor 2 (Nrf2), thereby fulfilling an essential role in the replenishment of 
several antioxidants, including SOD2 and GSH (Gruhlke et al., 2016).  
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CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Materials 
FB1 was purchased from Sigma Aldrich (Johannesburg, South Africa (SA)). The human embryonic 
kidney (Hek293) cells were purchased from Highveld Biological (Johannesburg, SA). Cell culture 
reagents were acquired from Whitehead Scientific (Johannesburg, SA). Western blotting reagents 
were purchased from Bio-Rad (Hercules, CA). Antibodies and Promega kits were bought from 
Anatech (Johannesburg, SA). Other reagents were obtained from Merck (Darmstadt, Germany). 
 
3.2 FB1 and allicin preparation 
Stock solutions of FB1 (1468.5 µM) and allicin (1848.8 µM) were prepared in 0.1 M phosphate 
buffered saline (PBS, pH 7.4). These stocks were stored at 4 oC and diluted for subsequent assays.  
 
3.3 Cell culture  
The Hek293cell line was reconstituted by transferring a vial of cryopreserved cells into a sterile 25 
cm3 cell culture flask containing 10 ml of complete culture medium (CCM) comprising of Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10 % foetal calf serum, 25 mM HEPES, 1 
% L-glutamine and 1 % penicillin-streptomycin-fungizone. The flask was incubated for 4 hours (4 h) 
at 37 °C, in a 5 % CO2-supplemented incubator, after which the CCM was discarded and replaced 
with 5 ml of fresh CCM. Cells were maintained until 90 % confluence was reached. Confluent flasks 
were washed with phosphate-buffered saline (PBS); the cells were dislodged and counted (150 µl of 
CCM, 50 µl of trypan blue, 50 µl of cell suspension in an eppendorf and transferring 10 µl of this 
mixture onto a haemocytometer) for sub-culturing or storage. 
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3.4 Methylthiazol tetrazolium (MTT) Assay  
3.4.1 Principle 
The methylthiazol tetrazolium (MTT) assay was used to measure cell viability and cytotoxicity in 
Hek293 cells following exposure to FB1 and allicin respectively. The yellow MTT salt that crosses 
the membranes of living cells is reduced to a purple formazan product by mitochondrial succinate 
dehydrogenase (SDH) (Figure 3.1) and therefore reflects the number of viable cells (Abate et al., 
1998). The MTT assay generates a half maximum inhibitory concentration (IC50) that refers to a 
concentration that inhibits a population’s biochemical functioning by 50 %. The IC50 will be used as 
the treatment dose in subsequent assays. 
 
Figure 3.1 : Metabolic cellular reduction of yellow MTT salt into a purple formazan (Riss et al., 2004). 
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3.4.2 Protocol 
The Hek293 cells were seeded into a 96-well microtitre plate at a density of 15,000 cells/well (200 
µl) in triplicate and allowed to attach overnight. Cells were incubated with a range of FB1 and allicin 
concentrations (0-1000 µM) at 37 °C for 24 h. Thereafter, the cells were incubated with 20 µl MTT 
salt solution (5 mg/ml in 0.1 M PBS) and 100 µl CCM at 37 °C. After 4 h incubation, the MTT salt 
was discarded and replaced with 100 µl of DMSO for the solubilisation of formazan crystals and 
further incubated for an hour at 37 0C. The optical density of the samples was read at 570 nm and 690 
nm using the Bio-Tek µQuant spectrophotometer (USA). The cell viability and the concentration 
dependent response curve were plotted using GraphPad Prism v5.0 software and an IC50 was 
generated. 
 
Flasks of Hek293 cells were grown to confluence and treated as follows: 
 control - CCM only 
 IC50 of FB1 
 IC50 of allicin and 
 Combined IC50 of FB1 + IC50 of allicin 
After 24 h treatment, the cells were washed, resuspended in PBS, counted and the cell number was 
adjusted for use in subsequent assays. 
 
3.5 Bioluminescence Assays 
Bioluminescence is the generation and emission of light by an organism due to a chemical reaction 
whereby chemical energy is transformed into light energy and the outcome is chemiluminescence 
(Hastings, 1968). The assay is based on the luciferin-luciferase reaction that occurs in the firefly. 
Luciferase is the enzyme that catalyses the monooxygenation of D-luciferin in the presence of 
magnesium, ATP and oxygen, producing inactive oxyluciferin. The intensity of light that is produced 
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by this reaction is directly proportional to the concentration of the substrate being measured (Lundin, 
2000). 
 
3.5.1 CytoTox-ONETM Homogenous Membrane Integrity Assay 
3.5.1.1 Principle 
While the MTT assay was used to estimate the number of viable cells, studies have shown that it is 
invaluable to measure the leakage of cytoplasmic components into the surrounding culture medium 
in order to quantify non-viable cells. This assay quantifies the fluorescent signal generated by 
resofurin when lactate dehydrogenase (LDH) released from cells with damaged membranes into the 
culture medium  participates in a coupled reaction that results in the conversion of resazurin to 
resofurin (Figure 3.2) (Ronken, 2009).  
 
Figure 3.2 : Leakage of LDH from a cell with a damaged membrane (Ronken, 2009). 
 
3.5.1.2 Protocol 
The protocol was followed according to the manufacturer’s instructions. Briefly, treated Hek293 cells 
(2 x 104 cells in 100 µl of treatment medium) were transferred to a 96-well white microtitre plate in 
triplicate and equilibrated to room temperature (RT). Lysis solution was added to all the wells (2 μl). 
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Thereafter, 100 µl of Promega CytoTox-ONE™ Reagent (#G7890) was aliquoted into all the wells 
and mixed well before incubation of 10 min at RT. Subsequently, 100 µl of stop solution was added 
into each well and the microtitre plate was put on the shaker for 10 sec. The fluorescence was obtained 
using the Promega GloMax®-Multi+ Detection Plate Reader (Turner Bio-systems, Sunnyvale, USA) 
with an excitation wavelength of 560 nm and an emission wavelength of 590 nm. 
% cytotoxicity = 100  x 
(experimental − culture medium background)
(max LDH release − culture medium background)
 
 
3.5.2 Caspases 
3.5.2.1 Principle 
The main workers of apoptosis are a family of proteins called caspases. These are cysteine-aspartate 
proteases that are involved in the initiation and execution of apoptosis (Garrido and Kroemer, 2004). 
The caspase activity is based on cleavage of the caspase-luciferin substrate by luciferase. This 
reaction produces light which is directly proportional to caspase activity (Figure 3.3). 
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Figure 3.3 : Luminometric measure of caspases 3/7, 8 and 9 activities [Adapted from (Riss et al., 2004, 
Brunelle and Zhang, 2010, Shunmugam, 2016)].  
 
3.5.2.2 Protocol 
The activities of caspase 3/7, 8 and 9 were detected with the Promega Caspase-Glo® assay (#G8091, 
# G8201 and #G8211 respectively). Briefly, 50 μl of cell suspension (20,000 cells/well in 50 µl 0.1 
M PBS) were seeded into duplicate wells of a white, opaque 96-well microtitre plate. As per 
manufacturer’s guidelines, caspase-Glo®-3/7 reagent was reconstituted and 50 μl was added into each 
well. Thereafter, the plate was incubated in the dark (30 min, RT). The procedure was completed in 
a similar fashion for caspase 8 and caspase 9. Luminescence was detected using a Modulus™ 
microplate luminometer (Turner Bio-systems, Sunnyvale, USA) as relative light units (RLU). 
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3.5.3 CellTiter-Glo® Luminescent Cell Viability Assay 
3.5.3.1 Principle 
ATP is the universal energy transducer in mammalian cells produced during cellular respiration. 
Levels of intracellular ATP are a useful indicator of respiratory capacity and mitochondrial function. 
The assay uses bioluminescence to determine intracellular ATP levels to indicate the number of viable 
cells in culture. During this reaction, cellular ATP is used in the luciferase reaction to generate a light 
signal (Figure 3.4).  The intensity of light that is produced by this reaction is directly proportional to 
the concentration of intracellular ATP (Lundin, 2000).  
 
Figure 3.4 : ATP-dependant oxidation of D-luciferin to produce light (Govender, 2016).  
 
3.5.3.2 Protocol  
The ATP inside the cells was quantified using the Promega CellTitre-Glo® Assay (#G7570), whereby 
50 µl of cell suspension (20,000 cells/well in 50 µl 0.1M PBS) was plated into a 96-well luminometer 
plate in duplicate. Thereafter, 50 µl of reconstituted CellTiter-Glo® substrate was added in each well. 
The plate was incubated in the dark for 30 min at RT. The amount of light produced was quantified 
using the Modulus™ microplate luminometer (Turner Bio-systems, Sunnyvale, USA) and expressed 
in RLU. 
 
3.5.4 Mitochondrial Toxicity Assay  
3.5.4.1 Principle 
The Promega Mitochondrial ToxGlo™ Assay (#G8000) serves to predict the integrity of the 
mitochondria and cellular ATP levels by looking at specific biomarkers that correspond with the 
normal functioning and state of the mitochondria. This assay achieves such by measuring protease 
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activity that shows cell membrane integrity and measures ATP levels through a luminescent signal 
(Figure 3.5).  
 
Figure 3.5 : Luminometric measurement of protease activity and ATP in the mitochondria (PT. Indolab utama 
protocols).  
 
3.5.4.2 Protocol  
To a white 96-well microtitre plate, 50 µl of Hek293 cell suspension (20,000 cells) was added into 
each well and the cells were allowed to attach overnight at 37 oC (5 % CO2). Cells were treated in 
duplicates for 24 h; then 20 µl of 5X cytotoxicity reagent was added into each well, mixed then 
incubated for 30 min at 37 0C. Fluorescence was then measured at 485 nmEx/520–530 nmEm. The 
assay plate was then equilibrated to room temperature for 10 min before the addition of 100 µl ATP 
Detection Reagent to each well and mixed for 5 min. The luminescence was then measured after 1 
hr.   
 
3.5.5 Ros-Glo H2O2 Assay 
3.5.5.1 Principle 
ROS are generated from the normal metabolic processes that occur in our body. The overproduction 
of ROS leads to oxidative stress that causes DNA and protein damage as well as lipid peroxidation. 
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The O2
- is the most common source of ROS. Superoxide is converted to H2O2 by SOD. This assay 
serves to measure the amount of H2O2 by coupling it in a luciferase reaction where the light produced 
is quantified (Figure 3.6). It also directly links the amount of H2O2 to O2
- production.  
 
Figure 3.6 : The chemistry of ROS-Glo™ H2O2 Assay (Promega protocols). 
 
3.5.5.2 Protocol 
Hek293 cells were seeded into a 96-well plate with their respective treatments (80 µl) and allowed to 
attach in 24 h incubation (37 oC at 5 % CO2). The H2O2 substrate was thawed and diluted accordingly. 
Thereafter, 20 µl of the H2O2 substrate was added into each well and incubated for 6 h (37 
oC at 5 % 
CO2). Subsequently, 100 µl of the ROS-Glo
TM detection solution was pipetted into each well and 
incubated for 20 min at RT. The luminescence was recorded using a Modulus™ microplate 
luminometer (Turner Bio-systems, Sunnyvale, USA) and was analysed as RLU. 
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3.5.6 Glutathione Assay  
3.5.6.1 Principle 
Glutathione is an antioxidant that can prevent damage to vital cellular components caused by ROS 
such as free radicals and lipid peroxides. This assay serves to quantify GSH levels based on the 
conversion of a luciferin derivative into luciferin in the presence of glutathione. This conversion is 
catalysed by glutathione S-transferase (GST). The signal generated is proportional to the amount of 
glutathione present in the sample (Figure 3.7). 
 
Figure 3.7 : GSH-Glo™ Glutathione assay overview (Promega protocols). 
 
3.5.6.2 Protocol  
In a 96-well white plate, 20,000 treated Hek293 cells were added and incubated (37 oC at 5 % CO2). 
GSH standards were prepared according to the manufacturers guidelines and added to the wells in 
duplicate. Thereafter 100 µl of the 2X GSH-Glo™ reagent was pipetted into each well. The plate was 
then incubated for 30 min at RT. Thereafter, 100 µl of the Luciferin Detection reagent was added into 
each well and briefly mixed before an incubation of 15 min at RT. The luminescence was then 
measured with the use of a Modulus™ microplate luminometer (Turner Bio-systems, Sunnyvale, 
USA) and recorded as RLU. 
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3.6 Single Cell Gel Electrophoresis (SGCE) Assay 
3.6.1 Principle 
 DNA fragmentation in individual cells is detected by the comet assay (Figure 3.8). DNA 
fragmentation is a late characteristic of apoptosis, a result of the chain reaction that occurs due to the 
caspase cascade. Healthy, undamaged DNA maintains a highly organised, supercoiled structure 
within the nucleus whilst damaged DNA loses its structural organisation and migrates out of the 
nucleus when subjected to an electric field (Godard et al., 1999). When an electric field is applied to 
cells embedded in agarose gel, DNA migration out of the nucleus forms a ‘comet’, where the head 
contains intact, undamaged DNA and the tail contains damaged, fragmented DNA. The comet assay 
utilises fluorescence microscopy to visualise the presence and extent of DNA damage (Singh et al., 
1988). 
 
Figure 3.8 : An overview of the comet assay process (Sigma-aldrich protocol).  
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3.6.2 Protocol  
Frosted end microscope slides were used for the SCGE assay (2 for each treatment). The slides were 
prepared with three layers: the first layer consisted of 2 % low melting point agarose (LMPA,  800 
µl) covered with a coverslip at the top of the gel and was set at 4 oC for 10 min; the second layer 
consisted of 1 % LMPA (400 µl) with Gel Red (1 µl) and cell suspension (20,000 cells in 30 µl 0.1 
M PBS) covered with a coverslip and solidified at 4 oC for 10 min; and the third and last layer 
consisted of 1 % LMPA (400 µl) covered with a coverslip at the top, which was left to set at 4 oC for 
10 min. The same procedure was repeated for all the slides. 
 
Coverslips were removed and solidified gels were submerged in cold cell lysis buffer [100 mM 
EDTA, 2.5 M NaCl, 1 % Triton X-100, 10 % DMSO, and 10 mM Tris (pH 10)] for 1 h at 4 °C. 
Thereafter, the slides were submerged in electrophoresis buffer [1 mM Na2 EDTA (pH 13) and 300 
mM NaOH] for 20 min at RT to allow for equilibration prior to electrophoresis (25 V, 35 min at room 
temperature) using a Bio-Rad compact power supply. 
 
The slides were rinsed three times (5 min each) in (0.4 M Tris, pH 7.4) to neutralise the samples prior 
to replacement of coverslips. The slides were then viewed using a fluorescent microscope (Olympus 
IX51 inverted microscope, excitation: 510-560 nm; emission 590 nm). Images of 50 cells and comets 
were captured from each slide. The comet tail lengths were quantified using a Soft Imaging system 
and reported as tail lengths in µm. 
 
3.7 Thiobarbituric acid reactive substances (TBARS) Assay 
3.7.1 Principle  
The detection of oxidative stress has relied largely on the quantification of compounds such as 
malondialdehyde (MDA), which are formed by degradation of initial products of free radical attack 
on membrane lipids (Oakes and Van Der Kraak, 2003). The reaction of MDA with 2-thiobarbituric 
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acid (TBA) produces a coloured product that can be detected at 532 nm (Figure 3.9). This assay is 
therefore one of the most widely used estimators of oxidative stress that measures MDA production, 
an indication of lipid peroxidation induced by oxidative stress. 
 
Figure 3.9 : Formation of MDA /TBA compound via the TBARS assay [Adapted from R&D systems 
protocol].  
 
 
3.7.2 Protocol  
The supernatants of each treatment (200 μl) were added into appropriately labelled, clean glass test 
tubes in duplicates containing 200 μl of 2 % phosphoric acid (H2PO4). A positive (containing MDA) 
and negative control (CCM only) was included in this experiment. Thereafter, 400 μl of 
TBA/Butylated hydroxytoluene (BHT) solution was added to every sample except the negative 
control, this tube received 400 μl of 3 mM HCl.  
 
Each test tube was briefly vortexed, and the pH of each sample was adjusted to 1.5 using 1 M HCl. 
The tubes were subsequently boiled in a water bath for 15 min at 100 °C to allow for optimal 
hydrolysis of MDA-adducts. After the samples cooled to RT, 1500 μl of butanol was added to each 
tube to extract MDA by separating the solution into two phases. The tubes were then vortexed and 
allowed to stand for the distinction of the two phases. 
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Lastly 200 μl of the upper butanol phase in each test tube was transferred to a 96-well microtitre plate 
in duplicates. The absorbance was measured at 532 nm with a reference wavelength of 600 nm using 
a Bio-Tek μQuant spectrophotometer (USA). 
 
3.8 Nitric Oxide Assay 
3.8.1 Principle  
Reactive nitrogen species (RNS) are formed when nitric oxide (NO) reacts with superoxide to 
produce peroxynitrite. It is therefore important to evaluate the production of NO to determine if 
nitrosative stress is present. The assay indirectly quantifies NO and therefore gives a measure of the 
RNS present. 
 
The nitric oxide assay is a traditional method used to measure the conversion of L-[3H] arginine to 
L-[3H]citrulline. However, because nitric oxide is oxidised to nitrates and nitrites in biological 
samples, it is these end-products that are quantified in this two-step reaction assay used to measure 
oxidative stress. The Greiss reaction is used as follows: vanadium (III) chloride (VCl3), 
sulphanilamide (SULF) and N-1-Naphthyl ethylenediamine dihydrochloride (NEDD) are each added 
in quick succession to facilitate reduction, inhibition of enzymatic reactions involving para-
aminobenzoic acid and colour change (detected at 540 nm) respectively (Figure 3.10) (Beda and 
Nedospasov, 2005).    
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Figure 3.10 : Nitric oxide assay represented by a two-step azotisation reaction that produces a diazo product 
(Bryan and Grisham, 2007). 
 
3.8.2 Protocol  
Sodium nitrate standards were prepared with a concentration range of 0–200 µM and 50 µl of each 
standard as well as the respective treatments were plated into a 96 well plate in duplicate. 
Subsequently, 50 µl VCl3 and 25 µl SULF were added in all the wells (standards and samples) 
followed by the addition of 50 µl NEDD. The plate was then incubated at 37 °C for 45 min. Following 
incubation, the plate was read and quantified using a Bio-Tek µQuant plate reader (USA) at a 
wavelength of 540 nm and a reference wavelength of 690 nm. A standard curve using the standards 
was then plotted and the concentration of RNS of the samples was extrapolated from the graph. 
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3.9 Western Blotting 
3.9.1 Principle 
Western blotting is an analytical technique used to detect the proteins in a homogenous sample. It 
relies on the principle that the proteins are separated through a sodium dodecyl sulfate (SDS)-
Polyacrylamide gel using an electric field (Figure 3.11). The extent of migration is determined by the 
size of the proteins. The proteins are then transferred onto a nitrocellulose membrane and 
immunoprobing takes place for the actual western blot (Figure 3.12). Proteins are represented as 
bands at the site of the antigen-antibody reaction and the band width is proportional to the quantity 
of the respective protein (Mahmood and Yang, 2012). Antioxidant and apoptotic proteins were 
quantified via western blotting. 
 
3.9.2 Protocol  
Crude protein was isolated from treated cells using CytobusterTM reagent containing protease and 
phosphatase inhibitors (300 µl). Flasks were placed on ice for 15 min, and then cells were scraped off 
the flasks and transferred to 1.5 ml eppendorf tubes which were also placed on ice for a further 15 
min. The cells were then centrifuged at 2 000 x g for 5 min (4 oC) to remove cellular debris. The 
crude protein obtained was quantified using the bichinchoninic acid (BCA) assay.  
 
Bovine serum albumin (BSA) standards (0–1 mg/ml) were prepared to determine the concentration 
of the protein samples. The standards and samples were then pipetted (25 µl) in duplicate into a 96-
well microtiter plate. The BCA reagent (198 µl BCA: 4 µl CuSO4) was added in each well (200 µl) 
and incubated at 37 oC for 30 min. The absorbance was detected using Bio-Tek µQuant 
spectrophotometer (USA) at 562 nm. A standard curve was constructed and proteins were 
standardised to 1 mg/ml. Laemmli buffer (dH2O, 0.5 M Tris-HCl (pH 6.8), glycerol, 10 % SDS, β-
mercaptoethanol , 1 % bromophenol blue) was added to each sample (1:4, total volume 250 µl), and 
heated to 100 °C (5 min). 
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Figure 3.11 : Western blot procedure from sample preparation to protein electrophoresis [Adapted from 
Creative Diagnostics protocol]. 
  
The standardised, denatured proteins (25 µl) were loaded onto a SDS-polyacrylamide gel (10 % 
resolving gel and 4 % stacking gel) to separate proteins (1.5 h at 150 V) using running buffer (Tris, 
glycine, SDS, dH20), after which transfer onto nitrocellulose membranes was achieved with transfer 
buffer (Tris, glycine, methanol, dH2O) using the Transblot 
®TurboTM Transfer system (Bio-Rad). 
Membranes were blocked with 5 % BSA in Tween20 Tris-buffered saline (TTBS, 25 mM Tris (pH 
7.5) 150 mM NaCl, 0.05 % Tween 20) for 2 h, and incubated with primary antibodies (GPx1 [#3286], 
SOD2 [#13141], Nrf2 [#12721], p53 [#48818], Bax [#5023], cPARP [#9542], catalase [#12980] and 
Hsp70 [#46477]) in 5 % BSA/TTBS (1:1000 dilution) overnight. The primary antibody was removed 
and membranes were washed five times with TTBS (10 min each), then incubated in secondary 
antibody (anti-rabbit IgG [#7074] or anti-mouse IgG [#70746]) as required, in 5 % BSA/TTBS 
(1:2500 dilution) for 2 h. Following incubation, membranes were washed with TTBS (5x 10 min 
each). Clarity Western ECL Substrate (Bio-Rad) (150 µl) was added to the membranes and images 
were captured using a Molecular Imager® ChemidocTM XRS and BioRad imaging system and actin 
[#12141] as a loading control. 
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Figure 3.12 : Representation of  immunoblotting  illustrating the binding of a primary antibody onto the target 
protein, followed by the secondary antibody-enzyme conjugate. This then allows for the emission of a 
chemiluminescent detection signal (elabscience protocols).  
 
3.10 Quantitative- Polymerase Chain Reactions (qPCR)  
3.10.1 Principle  
Quantitative- Polymerase Chain Reactions (qPCR) also known as real time PCR, is a reliable 
technique that both detects and measures products of the PCR process. When the PCR product is 
directly proportional to the amount of template DNA from the beginning of the PCR process, data is 
then collected in the exponential growth stage (Arya et al., 2005). The qPCR process occurs in two 
steps, first mRNA is isolated from cells, and then the mRNA is reverse transcribed to single-stranded 
complementary DNA (cDNA). Furthermore, qPCR is characterised by the addition of a fluorescent 
dye, SYBR green to the master mix (SYBR green, nuclease-free water, forward and reverse primer) 
(Hernandez-Rodriguez and Ramirez, 2012).  
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3.10.2 Protocol  
Cells with the relevant treatments were washed once with 0.1 M PBS. The total RNA was isolated in 
a series of steps. Briefly, 500 μl PBS and 500 μl Triazol was added to the flask and incubated at RT 
for 5 min. Thereafter, the flasks were scraped and the contents were transferred to 1.5 ml micro-
centrifuge tubes and stored at -80 ºC overnight. Thereafter, 100 μl chloroform was added to the 
thawed samples and mixed vigorously for 15 sec. The samples were incubated at room temperature 
for 3 min. The micro-centrifuge tubes were then centrifuged (12000 x g, 4 ˚C for 15 min), and the 
upper aqueous layer was transferred to a new 1.5 ml micro-centrifuge tube, which was placed on ice. 
Subsequently, 250 μl isopropanol was added to each sample and incubated on ice for 2 h before being 
returned to -80 ºC overnight. Samples were thawed again and centrifuged (12000 x g, 4 ºC for 20 
min). The resulting pellet contained the total RNA and was washed with 500 μl cold 75 % ethanol. 
Samples were then centrifuged again (7400 x g, 4 ºC for 15 min). All ethanol was discarded and the 
pellet was left to air-dry, before re-suspending in 15 μl RNase-free water. RNA samples were 
incubated at RT (3 min). A Thermo Scientific™ Nanodrop 2000 (Thermo Fisher Scientific; 
Johannesburg, South Africa) machine was used to determine the quality and quantity of the isolated 
RNA. The absorbance ratio of 260 nm/280 nm was used to determine purity of samples (~2). RNA 
samples were standardised to a concentration of 1000 ng/μl with RNase-free water and stored at -80 
°C until required. 
 
RNA was reverse transcribed to cDNA as per manufacturers’ guidelines using the iScript™ cDNA 
Synthesis kit (Bio-Rad; 107-8890): a 20 μl reaction volume containing 1 μl iScript™ reverse 
transcriptase, 4 μl 5X iScript™ reaction mix and the RNA template (2000 ng) made up in nuclease 
free water. Thermocycler conditions were set to 25 °C for 5 min, 42 °C for 30 min, 85 °C for 5 min 
and a final hold at 4 °C. The cDNA was diluted 1:4 to obtain a final volume of 100 µl. 
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Gene expression was analysed using the iQ™ SYBR Green Supermix (Bio-Rad; 170-880), according 
to the manufacturer’s instructions. Briefly, 1.5 μl cDNA template, 1 μl sense primer, 1 μl antisense 
primer, 5x iScript reaction mix and nuclease free water was made up to a reaction volume of 25 μl. 
The gene of interest was SOD2 [forward 5’-CAGCCCAGCCTGCGTAGACGG-3’; reverse 5’-
GCGTTGATGTGAGGTTCCAG-3’ (57 °C)]. All primers were obtained from Inqaba 
Biotechnologies (Pretoria, South Africa). 
 
The qPCR experiments were conducted using the CFX Touch™ Real Time PCR Detection System 
(Bio-Rad; Hercules, California, United States). The assay was run with three replicates per treatment. 
GAPDH [forward 5’-CGTGGAAGGACTCATGACCA-3’; reverse 5’ -
GCCATCACGCCACAGTTTC-3’ (57 °C)] was used as a housekeeping gene and was amplified 
simultaneously under the same conditions as the treatment samples. The reaction was subjected to an 
initial denaturation (95 °C, 4 min), followed by 37 denaturation cycles (95 °C, 15 sec), an annealing 
phase (57 °C, 40 sec), and an extension phase (72 °C, 30 sec). 
 
The acquired data was analysed using the method described by Livak and Schmittgen (2001) 
represented as fold-change in mRNA expression (2-ΔΔCT) relative to the control (Livak and 
Schmittgen, 2001). 
 
3.11 Statistical analysis 
The data acquired was expressed as mean optical density with standard deviations for the MTT assay 
and IC50 was determined using the dose-response inhibition equation (Log inhibition versus variable 
slope). For the data obtained from subsequent assays, the One-way ANOVA and an unpaired t-test 
with Welch’s correction was performed. The data was represented as means ± standard deviations. A 
p value of 0.05 was considered to be statistically significant. These statistical tests are available on 
GraphPad prism version 5.0 software. 
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CHAPTER 4: RESULTS 
 
The results obtained from the experiments elaborated in Chapter 3 will be outlined. Each reported 
result is accompanied by a graphical illustration that shows the major changes that occurred following 
treatment with FB1, allicin and a combination of FB1 and allicin.  
 
4.1 Methyl-thiazol-tetrazolium (MTT) Assay  
The dose-response of FB1 and allicin was assessed using the MTT assay and generated the IC50 for 
use in this study. The cell viability decreased to 76 % at 50 µM FB1, 72 % at 125 µM FB1 and 29 % 
at 250 µM FB1; yielding an IC50 of 215 µM FB1 (Figure 4.1A). Allicin induced a decrease in cell 
viability to consistently less than 30 % from 5 – 150 µM, and an IC50 of 3.905 µM was derived 
(Figure 4.1B). 
 
Figure 4.1 : The percent cell viability of Hek293 cells treated with varying concentrations of FB1 (A) and 
allicin (B) respectively was decreased with increasing doses when compared to an untreated control. The 
curves were used to calculate the IC50 of both exposures. 
 
 
4.2 CytoTox-ONE™ Homogeneous Membrane Integrity Assay 
The CytoTox-ONE™ homogeneous membrane integrity assay was used to measure the release of 
LDH from cells as an indicator for cytotoxicity (Figure 4.2). Basal LDH level in untreated cells was 
16700 ± 0.002983 RLU. Individual FB1 and allicin treated Hek293 cells showed a slight reduction in 
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cell membrane damage, whilst LDH release in combined FB1+allicin treated cells increased to 35150 
± 6450 RLU, indicating significant cell membrane damage and cytotoxicity. 
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Figure 4.2: Slightly decreased LDH levels in individual FB1 and allicin treated cells. LDH was significantly 
increased to 35150 ± 6450 RLU in combined FB1+allicin treated cells. One-way ANOVA with Tukeys post-
test – p = 0.0015. 
 
4.3 Mitochondrial ToxGlo™ Assay  
The mitochondrial integrity was assessed by measuring protease activity (Figure 4.3). There was a 
decrease in the mitochondrial integrity of FB1 treated cells, while a 1.65-fold increase occurred in 
allicin treated cells and combined FB1+allicin treatment restored mitochondrial integrity to control 
levels (313.0 ± 100.6). 
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Figure 4.3 : Decrease in mitochondrial integrity of FB1 treated cells (p = 0.7102), an increase in allicin treated 
cells (p = 0.3797) and a slight decrease in FB1+allicin treated cells compared to the control. 
 
4.4 Adenosine Triphosphate (ATP) Assay 
The ATP concentration in Hek293 cells was assessed using luminometry. There was a significant 
increase in ATP levels for all treatments (Figure 4.4). FB1 exposure resulted in a 50 % increase in 
ATP concentration (p = 0.0003). Allicin caused a slightly greater increase of 1.62-fold (p = 0.0024), 
while a significant 1.69-fold increase was observed in the combined FB1+allicin treatment (p < 
0.0001) when compared to the control (8989000 ± 76750). 
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Figure 4.4: Significantly increased ATP levels in all HEK293 cell treatments relative to the control (8989000 
± 76750). 
 
4.5 Free radicals 
4.5.1 Reactive oxygen species 
This assay measures the amount of H2O2 in the cell. The results demonstrate increased levels of H2O2 
in all treatments (Figure 4.5A) with a 1.43-fold (p = 0.0671) in FB1, 1.06-fold in allicin (p = 0.5369) 
and 1.66-fold in FB1+allicin (p = 0.0002) treated cells compared to the control (63430 ± 4343).  
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Figure 4.5A : Increased H2O2 levels in all HEK293 cell treatments relative to the control (63430 ± 4343). 
 
4.5.2 Nitric Oxide Assay (NOS)  
This assay measures the production of RNS. All three treatments showed a slight decrease in RNS 
formation (Figure 4.5B). Treatment with FB1 causing a 33 % decrease in RNS (p = 0.0177), while 
allicin and FB1+allicin resulted in 1.24-fold and 1.49-fold decreases respectively relative to control 
(11.14 ± 0.7021). 
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Figure 4.5B : Decreased levels of RNS formation in all three HEK293 cell treatments relative to the control 
(11.14 ± 0.7021).  
 
4.6 Thiobarbituric Acid Reactive Substances (TBARS) Assay 
ROS-induced lipid peroxidation as an oxidative stress marker was assessed by quantifying 
extracellular levels of MDA. Extracellular MDA levels were significantly reduced for all treatments 
of Hek293 cells (Figure 4.6). A 1.92-fold decrease in FB1 (p < 0.0001), 2.28-fold decrease in allicin 
(p < 0.0001) and a 1.27-fold decrease in combined FB1 + allicin (p = 0.0001) treated cells was noted 
compared to the control (0.5855 ± 0.009887).   
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Figure 4.6 : Significantly reduced levels of extracellular MDA in all HEK293 treatments relative the control 
(0.5855 ± 0.009887) - *** significantly different from the control. 
 
4.7 Glutathione (GSH) Assay 
The GSH concentration was measured as a marker for intracellular antioxidant capacity. The results 
showed that FB1 did not significantly alter GSH concentration (Figure 4.7). However, a 1.34-fold 
decrease and 1.66-fold decrease in the allicin (p = 0.0017) and combined FB1+allicin (p = 0.0025) 
treated cells was noted compared to the control (1.225 ± 0.02307) (Figure 4.7).  
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Figure 4.7: GSH concentrations relative to the control (1.225 ± 0.02307) show slight decrease in FB1 treatment 
and significant decrease in both allicin (p = 0.0017) and combined FB1+allicin (p = 0.0025) treated HEK293 
cells. 
 
4.8 Single Cell Gel Electrophoresis (SCGE) Assay 
The comet assay was used to measure the length of comet tails as an indicator of DNA damage. All 
HEK293 cell treatments increased DNA damage shown by the significant increase in comet tail 
length (Figure 4.8). FB1 increased by 1.5-fold (p < 0.0001), allicin increased by 1.29-fold and 
FB1+allicin increased by 1.47-fold compared to the control (8.634 ± 0.4910). 
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Figure 4.8 : Control cells (A) displayed an intact core of DNA, while FB1 (B), allicin (C) and combined 
treatment (D) all caused migration of fragmented DNA from the nucleus, forming a comet tail. Significantly 
increased comet tail lengths were visualised for all HEK293 treatments relative to the control (8.634 ± 0.4910).  
 
47 
 
4.9 Caspases 
The activity of caspases 8, 9 and 3/7 were assessed using luminometry. Caspases 8 (Figure 4.9A) and 
9 (Figure 4.9B) demonstrate a significant upregulation in all Hek293 cell treatments: caspase 8 
increased by 1.68-fold in FB1 (p = 0.0003), 1.94-fold in allicin (p = 0.0008) and 2.33 in FB1+allicin 
(p = 0.0023) treated cells relative to the control (2204000 ± 10750), and caspase 9 increased by 1.53-
fold in FB1 (p < 0.0001), 1.85-fold in allicin (p < 0.0001) and 2.24-fold in FB1+allicin treated cells 
(p < 0.0001) relative to the control (5112000  ± 56180). Caspase 3/7 activity (Figure 4.9C) was 
significantly increased by 2.19-fold in the allicin-treated cells (p < 0.0001) and doubled in the 
combined treatment FB1 + allicin treatments (p < 0.0001) when compared to the control (261700 ± 
2835).  
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Figure 4.9: Caspase activity following cell exposure to FB1, allicin and FB1+allicin. (C) Executioner caspase 
3/7 showed a slight decrease in FB1 treated cells and a significant increase in subsequent treatments (***p < 
0.0001). (B) Initiator caspase 8 (A) and 9 were significantly upregulated for all treatments.  
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4.10 Western blots 
Western blotting was used to determine oxidative stress (Figure 4.10A) and apoptotic protein (Figure 
4.10B) expression.  
 
Oxidative stress markers included SOD2, catalase, GPx1, Nrf2 and HSP70 (Figure 4.10A). SOD2 
was significantly downregulated for all Hek293 cell treatments presenting with a 1.42-fold decrease 
in FB1, a 1.72-fold decrease in allicin and a 2.75-fold decrease in FB1+allicin relative to the control 
(2.208 ± 0.03848). Likewise, catalase expression was decreased for all treatments, and the most 
significant depletion was noted in the combined treatment. In contrast, all three treatments 
significantly upregulated the expression of GPx1 relative to the control, with the upregulation less 
significant in the combined treatment. The expression of Nrf2 was also upregulated with a synergistic 
effect in the FB1+allicin compared to the control (0.3734 ± 0.1084). HSP70 expression was not 
markedly deviated from the control, with only slight increases occurring in the FB1 and combined 
treatments.  
 
Apoptotic markers probed for were Bax, cPARP and p53 (Figure 4.10B). Bax was significantly 
increased relative to the control. Allicin increased Bax expression slightly more that FB1 alone. 
However, allicin treatment did not result in PARP cleavage, as was noted in the FB1 and FB1+allicin 
treatments.  p53 was increased by 1.22-fold for FB1, but the allicin increase was not significant and 
the combined FB1+allicin treatment was unchanged when compared to the control.  
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Figure 4.10A: Protein expression for oxidative stress following HEK293 treatments. Nrf2 was upregulated for 
all treatments relative to the control (0.3734 ± 0.1084). HSP70 was only decreased in the allicin treatment. The 
expression of GPx1 was upregulated in all treatments. SOD2 expression was significantly downregulated. 
Catalase was overall decreased for all treatments. 
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Figure 4.10B: Protein expression for apoptotic markers following Hek293 cell treatments. BAX was 
significantly increased for all treatments. p53 was upregulated for both FB1 and allicin at 1.22-fold and 1.06-
fold respectively. cPARP expression was increased for all treatments relative to the control (0.4867 ± 0.02153).  
 
4.11 Quantitative- Polymerase Chain Reactions (qPCR) 
Hek293 treatments were assessed to determine the mRNA levels of SOD2 (Figure 4.11). FB1 and 
allicin increased mRNA levels. The combined FB1+allicin treatment decreased the mRNA levels of 
SOD2 relative to the control (0.9725 ± 0.02496).  
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Figure 4.11: SOD2 was increased for both FB1 and allicin at 1.02-fold and 5.87-fold respectively. The 
combined FB1+allicin treatment was significantly decreased. 
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CHAPTER 5: DISCUSSION 
 
FB1 is a vastly studied mycotoxin produced as a secondary metabolite of Fusarium verticillioides 
known to contaminate crops. Studies have shown FB1 to be toxic in multiple cell lines of human and 
animal origin (Berek et al., 2001, Schmale and Munkvold, 2009). Although its mechanism of action 
remains unclear, many investigations performed on animal models demonstrate its effects on 
sphingolipid metabolism (Riley et al., 1994) and more recently, a new epigenetic influence 
(Chuturgoon et al., 2014) has been suggested . Overall, these mechanisms may result in dysregulation 
of protein synthesis and a variety of cytotoxic effects that include oxidative stress and cell death. The 
ubiquitous mycotoxin, FB1, is geographically associated with OC in humans and liver/kidney cancer 
in rats (Voss et al., 1993, Howard et al., 2001, Khan et al., 2018b). A recent study investigated its 
effects in HepG2 liver cancer cells (Chuturgoon et al., 2014). However, its role in kidney toxicity in 
humans has not been investigated.  
 
Garlic, a common medicinal plant has been used to treat various ailments over centuries. Its biological 
component allicin has been found to be responsible for many health benefits including anti-cancer 
properties through inhibition of cellular proliferation, inducing apoptosis and antioxidant activity to 
alleviate oxidative stress (Mikaili et al., 2013, Gruhlke et al., 2016). This study therefore sought to 
investigate the toxic effects of FB1 in Hek293 cells. In addition, the ability of allicin to ameliorate 
their effects was studied.  
 
Cytotoxicity was investigated using the MTT assay, which yielded an IC50 of 215 µM and 3.905 µM 
for FB1 and allicin respectively (Figure 4.1 A and B). The IC50 in other studies varied for different 
cell lines, eliciting effects at different concentrations (Agarwal, 1996, Ha and Yuan, 2004, Liao et al., 
2009, Suddek, 2014) The decreased cell viability indicates that both FB1 and allicin negatively 
influenced the mitochondrial ability to oxidise the MTT salt to its formazan product. Various studies 
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have shown that at varying concentrations, FB1 decreases viability (Rumora et al., 2002, Chuturgoon 
et al., 2015). However, Myburg et al. (2002) showed that FB1 had limited cytotoxicity in human OC 
SNO cells over 24 h and 48 h respectively (Myburg et al., 2002). With regards to allicin, studies have 
shown that it inhibits cell proliferation. According to Prager-Khoutorsky et al. (2007) this may be due 
to its effects on tubulin, thus the mitotic spindle will not form and cell division will be inhibited 
(Prager‐Khoutorsky et al., 2007, Gruhlke et al., 2016). 
 
 Mitochondrial function is pivotal both in the production of ATP and activation of the intrinsic 
pathway of apoptosis. In addition, mitochondria also produce ROS as by-products of energy 
metabolism. Thus, determination of mitochondrial health is important. In this study, only allicin 
demonstrated increased mitochondrial integrity relative to the control (Figure 4.3). Furthermore, ATP 
production was increased by all treatments (Figure 4.4). The increased ATP implies an active electron 
transport chain. Where mitochondrial integrity is compromised, that will inevitably result in the 
production of ROS. Allicin increased mitochondrial integrity. When ATP production is increased in 
intact mitochondria, there would be less leakage of electrons and therefore less iROS formed 
(Brookes et al., 2004), as demonstrated by the results. iROS were increased by FB1 and only slightly 
increased for allicin, while allicin failed to prevent iROS production in the presence of FB1 (Figure 
4.5A); in both instances, mitochondrial integrity was slightly lower relative to the control. However, 
RNS were decreased for all treatments (Figure 4.5B). Oxidative stress results from the production of 
ROS and an inadequate antioxidant response. In this study, the presence of oxidative stress is 
suggested by increased HSP70 in all treatments, where it appears that allicin potentiates the effects 
of FB1, as well as Nrf2 which was synergistically increased in the combined treatment (Figure 4.10A). 
 
An antioxidant response includes mobilisation of SOD2, catalase, GPx1, GSH and Nrf2. While 
downregulation of SOD2 protein expression occurred in all treatments (Figure 4.10A) its gene 
expression particularly increased (Figure 4.11) in the allicin treatments. Therefore, superoxide 
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conversion to H2O2 could not take place using SOD2. However, it may have been converted 
intracellularly by SOD1, a cytosolic enzyme isoform of SOD, into H2O2 (Birben et al., 2012). Khan 
et al. (2018b) demonstrated a decreased expression of SOD2 at 0-20 µM FB1 doses in SNO cells 
(Khan et al., 2018a). In addition, underlying pathways including protein degradation play a major 
role in mRNA gene expression and protein concentration. This is supported by Scholze et al. (2011) 
whose study found an increase in the gene expression of SOD1 in chronic kidney disease patients 
coupled with decreased protein expression (Scholze et al., 2011, Krueger et al., 2016). Catalase, the 
antioxidant responsible for the conversion of H2O2 to H2O was also decreased in the FB1 and in the 
combined treatment.  
 
The increased iROS levels therefore were not associated with SOD2 or catalase. The principle 
intracellular antioxidant is GSH; its depletion is usually an indication of oxidative stress (Forman et 
al., 2009). GSH was decreased by allicin and in the combined treatment (Figure 4.7), this is not 
surprising since allicin is a thiol agent that is known to oxidise GSH to GSSG, this has been confirmed 
by Gruhlke et al. (2016) who showed a decrease in GSH following administration of allicin (Gruhlke 
et al., 2016). In addition, GPx1 was increased (Figure 4.10A), which may account for the depletion 
of GSH; when GPx1 is activated to convert H2O2 to H2O, GSH is oxidised to GSSG. The reduction 
of GSSG requires glutathione reductase (GR) and NADPH, a cofactor derived from the pentose 
phosphate pathway (Patra and Hay, 2014). 
 
In the presence of cellular stress, HSP70 is expressed as a primary response sensor following protein 
misfolding (El Golli-Bennour and Bacha, 2011). This makes HSP70 a biomarker for oxidative stress. 
In this study, HSP70 indicated the presence of oxidative stress in the FB1 and combined treatment 
(Figure 4.5A). While an increase in ROS production (H2O2) is noted in the FB1 and combined 
treatment (Figure 4.5A), the antioxidant response is mobilised to ameliorate this effect. This is 
indicated by a depletion in the cellular antioxidants such as GSH, SOD and catalase (Figure 4.7, 10A). 
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Increased levels ROS are known to inactivate or deplete antioxidant enzymes (Lushchak, 2015), 
resulting in an accumulation or inadequate removal of ROS and  oxidative stress (Fukai and Ushio-
Fukai, 2011). For the allicin treatment, this utilisation of antioxidants kept H2O2 within normal limits, 
and oxidative stress was not present as indicated by HSP70 protein expression (Figure 4.10A). 
Increased Nrf2 (Figure 10A) explains the upregulation in the expression of GPx1 which in turn used 
up GSH to detoxify H2O2 (Ma, 2013), and is supported by research which shows that allicin elevates 
the levels of Nrf2 for the expression of other antioxidants to alleviate oxidative stress (Bat-Chen et 
al., 2010). A study on HepG2 cells demonstrated that transcription of antioxidant proteins was 
regulated by Nrf2 in FB1-treated cells (García-Trejo et al., 2016, Arumugam et al., 2018). However, 
the Nrf2 response that results in increased SOD gene expression in allicin-treated cells, does not occur 
in the combined treatments (Figure 4.11). Therefore, despite the enhanced protein expression of Nrf2 
following combination treatment, an accompanying replenishment of SOD will not occur. Thus 
allicin will not ameliorate the effects of FB1. Given the reduced SOD gene expression relative to the 
FB1-treatment suggests that allicin may increase oxidative stress in FB1-treated cells.  
 
While iROS were increased, there was no corresponding increase in lipid peroxidation (Figure 4.6). 
This decrease triggers the upregulation of antioxidant response molecules to maintain cellular 
homeostasis (Ayala et al., 2014). However, there was increased DNA fragmentation (Figure 4.8), 
which may be mediated by oxidative stress. When there is DNA damage, p53 is activated to initiate 
repair, cause cell cycle arrest or apoptosis. p53 was only slightly increased by FB1 and allicin (Figure 
4.10B) and was decreased in the combined treatments therefore repair mechanisms were not activated 
by allicin. DNA fragmentation is a morphological feature of apoptosis; therefore, in this study it may 
represent a late-stage marker for apoptosis. 
 
Apoptosis is a programmed cell death mechanism facilitated by a family of proteins called caspases; 
in this study caspase activities were evaluated. In all treatments, the initiator caspases 8 and 9 were 
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upregulated (Figure 4.9A, B) which suggests that apoptosis is initiated via the extrinsic and intrinsic 
pathways; indeed, both FB1 and allicin have been shown to induce apoptosis (Dragan et al., 2001, 
Oommen et al., 2004, Minervini et al., 2004, Bat-Chen et al., 2010)  Upon activation, these caspases 
initiate the apoptotic cascade that culminates in the cleavage of caspase 3/7 known as the executioner 
of apoptosis. However, the results show that FB1 did not increase caspase 3/7 (Figure 4.9C). It is 
possible that inhibitors of apoptosis (IAPs) may have blocked caspase 3/7 activation, by blocking 
apoptosis downstream of cytochrome c release by binding to and inhibiting active caspase 9 within 
the apoptosome, preventing downstream activation of procaspase 3/7. Chuturgoon et al.(2015) 
showed that BIRC 8, an IAP, was increased following FB1 administration in HepG2 cells, which may 
have been responsible for lack of execution caspase 3/7 activity despite caspase 9 activation 
(Chuturgoon et al., 2015). In addition the presence of mitochondrial proteins Smac/DIABLO and 
Omi/HtrA2 antagonise this inhibitory action (Burke et al., 2010, Parrish et al., 2013). Furthermore, 
HSP70 is an anti-apoptotic protein that can inhibit apoptosis upstream of caspase 3/7 activation; this 
can therefore be supported by the observed increase in HSP70 in FB1 treated cells (Figure 4.10A). A 
study on animal models also showed that FB1 increased the expression of HSP70 and this is inclined 
with our findings (Kócsó et al., 2018). 
 
An overall increase in caspase levels was noted in allicin and combined allicin and FB1-treated 
Hek293 cells (Figure 4.9C) suggesting caspase-dependant activation of apoptosis. These findings are 
in agreement with a study done by Oommen et al. (2004) on human cervical and colon cancer cells 
wherein allicin halted cancer growth through induction of caspase-dependent apoptosis. Their results 
showed an increase in 3, 8 and 9 as well as PARP cleavage (Oommen et al., 2004). Bax is responsible 
for the formation of mitochondrial pores to release cytochrome c. Our results demonstrated an overall 
increase in Bax expression (Figure 4.10B). Alternatively, mitochondrial toxicity associated with 
allicin treatment could be responsible for cytochrome c release and caspase activation.  
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Activated caspase 3/7 results in the cleavage of iCAD and PARP forming CAD and cPARP 
respectively. CAD is a DNase that cleaves DNA into 180 bases per unit and is associated with the 
fragmentation of DNA as seen in Figure 4.9. The PARP are a family of proteins that assist in DNA 
damage and repair by binding to and repairing detected single and double-stranded DNA breaks. 
Caspase 3 cleaves PARP and therefore renders it inactive. Oommen et al. (2004) showed increased 
cPARP in human cervical and human colon cancer cells (Oommen et al., 2004). Likewise, 10 µM 
FB1 treatment of SNO cells also caused an increase in cPARP (Khan et al., 2018a). Thus, allicin 
increased induction of apoptosis in the presence of FB1, which was expected since oxidative stress 
was present. If increased apoptosis is accompanied by compensatory cell proliferation to replenish 
damaged cells, then cancer could result. This is of particular concern since the combined treatment 
also decreased DNA repair.  
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CHAPTER 6: CONCLUSION 
 
 
This study sought to explore mechanisms of toxicity exerted by FB1 in a human kidney cell line 
coupled with the potential therapeutic properties of allicin on FB1 treated Hek293 cells. The results 
show that FB1 and allicin cause a decrease in cell viability. All three treatments increased MDA in 
conjunction with increased ATP production. However, H2O2 concentration was not altered by allicin. 
The activation of an antioxidant response occurred; Nrf2 and GPx1 were upregulated but SOD2 and 
catalase were decreased, suggesting alternative modes of oxidant detoxification. Apoptosis was 
triggered in all treatments via both intrinsic and extrinsic pathways, but execution in the FB1 treatment 
was not caspase-dependent. Cumulatively, FB1 and allicin individually trigger apoptosis, but only 
FB1 induced oxidative stress. When combined, a possible synergistic relationship is demonstrated in 
the expression of proteins. In addition, allicin caused decreased SOD2 gene expression in the presence 
of FB1 despite increased Nrf2 upregulation. Therefore, allicin did not exert a therapeutic effect on 
FB1-treated Hek293 cells.  
 
Following findings from this study, further investigations on the effects of IAP in FB1-induced 
apoptosis is recommended. The inflammatory pathway as a consequence of both allicin and FB1 on 
in vitro and in vivo models is also of interest for future studies. 
 
 While more research is required, allicin should not be recommended as a supplement to ameliorate 
the cytotoxic effects of FB1. This study only tested the IC50 concentrations of FB1 and allicin. Perhaps 
expanding the range of treatment concentrations can give a better picture of the interaction between 
FB1 and allicin. 
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APPENDICES 
 
Appendix A: Nitric oxide assay 
 
 
Figure 1: Mean absorbance values of NOS standard curve 
 
Appendix B: Glutathione (GSH) Assay 
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Figure 1: Mean absorbance values of GSH concentrations standard curve. 
 
 
Appendix C: Protein standardisation  
 
 
Figure 1: Standard curve for protein standardisation  
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